#Neurocovid #LongCovid #Neuroimmunology #neurobiology & #COVID19 #Clinicalperspectives Type I IFN signaling in the #choroidplexus epithelium after resolution of #SARSCoV2 infection may trigger a cascade of events leading to cognitive decline @NatImmunol
📌 https://www.nature.com/articles/s41590-022-01410-z
📌 https://www.nature.com/ni/
📌 https://www.nature.com/collections/aeacbbicec
#neurocovid #LongCovid #neuroimmunology #neurobiology #COVID19 #clinicalperspectives #choroidplexus #SarsCoV2
#OncologyResearch #Clinicalperspectives #CARTcell #Immunobiology and mechanisms of resistance .Targets of #CARTCell therapies with clinical evidence of efficacy
@Nature
https://www.nature.com/articles/s41586-023-05707-3.pdf
#oncologyresearch #clinicalperspectives #CARTCell #immunobiology
#oncologresearch @Nature #Clinicalperspectives #CARTCell #Immunobiology and mechanisms of resistance .Targets of #CARTCell therapies with clinical evidence of efficacy
📌 https://www.nature.com/articles/s41586-023-05707-3.pdf
📌 https://www.nature.com/nature/volumes/614/issues/7949
#oncologresearch #clinicalperspectives #CARTCell #immunobiology
@jama_current @cellpress #Clinicalperspectives The dynamic interplay of bacteriophage, bacteria &the host during phage therapy
📌 https://www.cell.com/iscience/pdf/S2589-0042(23)00081-0.pdf
📌 https://pubs.rsc.org/en/content/articlehtml/2023/ma/d2ma00980c
📌 https://www.medrxiv.org/content/10.1101/2023.01.23.22283996v1.full.pdf
📌 https://www.sciencedirect.com/science/article/pii/S1879625722001018
📌 https://www.sciencedirect.com/science/article/abs/pii/S1198743X23000332
@cellhostmicrobe @biorxivpreprint #Clinicalperspectives on Rethinking next-generation vaccines for #SARSCoV2 , influenzaviruses & other respiratory 🦠however the data indicate the bivalent vaccine booster strengthens protection against Omicron lineage variants
📌https://www.sciencedirect.com/science/article/pii/S1931312822005728
📌https://www.biorxiv.org/content/10.1101/2023.01.08.523127v1.full.pdf
📌 https://www.biorxiv.org/content/10.1101/2022.11.17.516898v1.full.pdf
#clinicalperspectives #SarsCoV2